The entrepreneur Claudio Cavazza, president of Sigma-Tau, passed away today in Rome at the age of 77, "leaving an unfillable void in his family, in all the employees of the Sigma-Tau Group which he founded in 1957, and in those in the business world who had worked and collaborated with him", reports a note from the pharmaceutical company.
After graduating in Pharmaceutical Chemistry - reads the note - Cavazza attended for some time the chair of Professor Noris Siliprandi, Full Professor of Biochemistry at the University of Padua, but soon chose to devote himself to entrepreneurial activity. His business as an entrepreneur in the pharmaceutical sector took off in the mid-1960s thanks to the launch of Rekord B12, which soon became one of the best-selling drugs in Italy and beyond. Another fundamental step in the history of the Sigma-Tau Group was the choice, due to Cavazza's passion and determination, to direct a large part of the economic-financial resources dedicated to scientific research for the study of metabolism and carnitines, substances of natural origin, endogenous and free of side effects, which intervene in the processes that allow the cell to obtain its own energy sources.
Cavazza was president of Farmindustria from 1986 to 1992. He was a member of the Presidency committee of Confindustria and was then called to join the Confindustria Technical Education Committee and the Steering Committee set up by the Confindustria Health Commission. In January 2008 he was appointed head of the 'New Technologies of Life' industrial innovation project of the Ministry of Economic Development. He was a board member of Efpia (European Pharmaceutical Industries Association), of which he was vice president from 1992 to 1994. He was also a board member of Ifpma (International Federation of Pharmaceutical Manufacturers Association).
In 1987 he was nominated Cavaliere del Lavoro. In 2005 - continues the note - the University of Genoa awarded him an Honorary Degree in Medicine. He received an Honoris Causa Degree in International Business Strategies from the Lustico – Free University of International Studies. In recognition of its commitment to rare disease research and development in the United States,
the County of Maryland established the Claudio Cavazza Science Award in 1995. In June 2005 it is
